Envision Healthcare Investor Center is your source for the latest investor relations information for the company, including news releases, SEC filings, financial reports and Corporate Governance.
http://investor.emsc.net/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
0.2 seconds
16x16
PAGES IN
THIS WEBSITE
12
SSL
EXTERNAL LINKS
0
SITE IP
204.8.173.155
LOAD TIME
0.157 sec
SCORE
6.2
Information from Envision Healthcare | | investor.emsc.net Reviews
https://investor.emsc.net
Envision Healthcare Investor Center is your source for the latest investor relations information for the company, including news releases, SEC filings, financial reports and Corporate Governance.
investor.emsc.net
IRS Disclosure | Information from Envision Healthcare
http://investor.emsc.net/irs_disclosure
Community and Government Leaders. Reducing Cost of Care. Investing in Your Success. Form 8937 * 10/1/12: Return of Capital Distribution. Community and Government Leaders. Reducing Cost of Care. Investing in Your Success.
Stock Information | Information from Envision Healthcare
http://investor.emsc.net/stock-chart
Community and Government Leaders. Reducing Cost of Care. Investing in Your Success. Community and Government Leaders. Reducing Cost of Care. Investing in Your Success.
Financial Reports | Information from Envision Healthcare
http://investor.emsc.net/financial-reports
Community and Government Leaders. Reducing Cost of Care. Investing in Your Success. EVHC 2015 Annual Report. EVHC 2014 Annual Report. EVHC 2013 Annual Report. EVHC 2012 Annual Report. EMSC 2011 Annual Report. EMSC 2010 Annual Report. EMSC 2009 Annual Report. EMSC 2008 Annual Report. EMSC 2007 Annual Report. EMSC 2006 Annual Report. EMSC 2005 Annual Report. EVHC 2014 Third Quarter 10-Q. EVHC 2014 Second Quarter 10-Q. EVHC 2014 First Quarter 10-Q. EVHC 2013 Third Quarter 10-Q. EVHC 2013 Second Quarter 10-Q.
Financial Releases | Information from Envision Healthcare
http://investor.emsc.net/news-releases/all/all/all
Community and Government Leaders. Reducing Cost of Care. Investing in Your Success. Envision Healthcare Reports Second Quarter Results. Envision Healthcare Holdings, Inc. to Report Operating Results for Second Quarter and First Half of 2016 on August 3, 2016. Envision Healthcare and AMSURG Announce Transformational Merger. Envision Healthcare Holdings, Inc. To Participate at Bank of America Merrill Lynch 2016 Healthcare Conference May 10, 2016. See all of our releases. EVHC In The News.
IRS Disclosure | Information from Envision Healthcare
http://investor.emsc.net/irs_disclosures
Community and Government Leaders. Reducing Cost of Care. Investing in Your Success. Form 8937 * 10/1/12: Return of Capital Distribution. Community and Government Leaders. Reducing Cost of Care. Investing in Your Success.
TOTAL PAGES IN THIS WEBSITE
12
e.l.f. Cosmetics, Inc.
Skip to main content. RETURN TO ELFCOSMETICS.COM. About e.l.f. cosmetics. Code of business conduct and ethics. About e.l.f. cosmetics. Code of business conduct and ethics. About e.l.f. cosmetics. Elf Cosmetics, Inc. Meet the high-performance team driving our success. Elf Beauty, Inc. makes luxurious beauty accessible for all women to. Elf Beauty, Inc. Announces Participation in the 19th Annual ICR Conference. To request information, please contact us.
Elk Homes LLC - Fully furnished apartments & single-family homes for temporary rental housing
Bronxville, New York. Hastings-on Hudson, New York. Irvington, New York. Larchmont, New York. Pelham Manor, New York. Rye, New York. Rye Brook, New York. Scarsdale, New York. White Plains, New York. For Investors - Overview. Elk Homes owns and operates rental residential properties in metropolitan New York suburbs directly and with affiliated entities. These properties are for the most part in premier communities such as Rye, New York; Scarsdale, New York; and Greenwich, Connecticut. In summary, we seek ...
Investor Relations | EMCORE
Skip to main navigation. CATV Broadband Transport and Access. 1550 nm Fiber Optic Transmitters. 1550 nm Optical Amplification-EDFA. Switches, Splitters, WDM Filters. CATV Lasers and Components. Analog Lasers, Photodiodes and Plug-in Receivers. CATV Lasers and Components. DFB Lasers and Receivers for Wireless. Avalanche Photodiode (APD) Chips. Satellite RF Fiber Optic Transport. Optiva Platform RF Fiber Optic Links. Enclosures and Power Supplies. Erbium Doped Fiber Amplifiers (EDFA). Send us a message.
emerchants Investors
Share Price and Graphs. Share Price and Tools. Share Price and Graphs. Emerchants primary focus is to grow its business and in turn deliver superior returns for our shareholders. As at 11:02AM 14/08/2015. 2014 emerchants Payment Solutions Limited (emerchants) ACN 131 436 532 AFSL 404131. Any advice does not take into account your personal needs and financial circumstances and you should consider whether it is appropriate for you. emerchants recommends you read the Terms and Conditions and/or Prod...
Copec Investor
US$ 1,575.00/T.M.B. 1Q15 Results and Conference Call Invitation available. Empresas Copec nominated for ALAS20 2015. 4Q14 Results and Conference Call. Environmental Impact Statement for Arauco’s dissolving pulp project obtained unanimous approval. Terpel makes successful bond placement of COP$400 billion. Empresas Copec S.A. completes a successful bond issue. Information regarding Empresas Copec 1Q15 Earnings Release and Conference Call. Itau Andean Conference - 08:00 AM. Itau Andean Conference - 08:00 AM.
Information from Envision Healthcare |
Investing in Your Success. Quote delayed by a minimum of 15 minutes. EmCare Review of Cooper Working Paper. Envision Healthcare Completes Divestiture of American Medical Response. 2017 Annual Meeting Materials. Investing in Your Success.
Matas A/S - Investor Relations
Interim report for the period 1 April 2015 to 30 June 2015. Aug 28, 2015. Matas will host a conference call for investors and analysts, Friday 28 August at 10.30 CET. The conference call and presentation will be available via Matas’ investor website: investor.matas.dk. Conference call access numbers for investors and analysts:. DK: 45 38 48 75 13. UK: 44 (0)20 3427 1908. US: 1 646 254 3364. Please dial in 5-10 minutes prior to the start time using the number / Conference ID below. View all ». Jul 31, 2015.
PANDORA - Investor Relations
Vice President, Head of Investor Relations. LOUISE GYLLING JØRGENSEN. Transactions in connection with share buyback programme. Transactions in connection with share buyback programme. Silent period Q1 2018. Interim Report for the first quarter 2018. Conference: HSBC Luxury Goods Conference - Paris. Conference: Deutsche Bank Global Consumer Conference - Paris.
investor.en.vostoknewventures.com
Vostok New Ventures Ltd. - Investor Relations
Vostok New Ventures Ltd. The Swedish Depository Receipts (SDRs) of Vostok New Ventures Ltd (formerly Vostok Nafta Investment Ltd) are listed on Nasdaq Stockholm, Mid Cap segment, with the ticker VNV SDB. View all ». Aug 12, 2015. Vostok New Ventures to release six Months Report 2015 Wednesday, August 19, 2015. Jul 30, 2015. Avito trading statement second quarter 2015. View all ». Featured Reports and Events. Interim report for the first three months 2015. May 20, 2015. May 20, 2015. Mar 31, 2015.
Investor Relations | Endocyte, Inc.
Skip to main navigation. EC0652 Prostate Cancer Molecular Imaging. Etarfolatide (EC20) Molecular Imaging. Investor relation header menu. Annual Reports and Proxies. More information is coming soon. Mar 15, 2018. Endocyte Announces Presentations at American Association for Cancer Research (AACR) Annual Meeting 2018. Mar 15, 2018. Endocyte Nominates Dawn Svoronos for Election to Its Board of Directors and Announces Other Board Developments. Mar 12, 2018 at 2:50 PM EDT. Feb 26, 2018 at 8:30 AM EST. Endocyte...
Investor Relations - Endologix
News & Events. Mar 20, 2018 at 8:30 AM ET. ENCORE Study Investor Conference Call. 015 ( 3.68%). 4:00 PM ET on Mar 29, 2018. Delayed at least 20 minutes. ENCORE Study Investor Conference Call. Mar 20, 2018 at 8:30 AM ET. Encore Ovation Analysis Presentation. File is in Briefcase. LEOPARD Trial Presentation – VEITH 2017. Nellix EVAS FORWARD IDE Data. LUCY Study 30-day Data Reveal. ASCEND Registry Presentation - Charing Cross 2016. Global Registry Podium Charing Cross 2016. Mar 19, 2018. Mar 5, 2018. The Ne...
